Sevelamer Improves Steatohepatitis, Inhibits Liver and Intestinal Farnesoid X Receptor (FXR), and Reverses Innate Immune Dysregulation in a Mouse Model of Non-alcoholic Fatty Liver Disease [PDF]
Brett McGettigan +7 more
openalex +1 more source
Discussing the role of circular RNA in the pathogenesis of non-alcoholic fatty liver disease and its complications [PDF]
MÉLISSA YEPMO +5 more
openalex +1 more source
Height predict incident non-alcoholic fatty liver disease among general adult population in Tianjin, China, independent of body mass index, waist circumference, waist-to-height ratio, and metabolic syndrome [PDF]
Shubham Kumari +15 more
openalex +1 more source
Features of the therapy of non-alcoholic fatty liver disease in comorbid patients
М. V. Maevskaya
openalex +2 more sources
Meta‐analysis of the effects of sodium glucose cotransporter 2 inhibitors in non‐alcoholic fatty liver disease patients with type 2 diabetes [PDF]
Binayak Sinha +2 more
openalex +1 more source
The Association Between Dietary Acid Load and Non-Alcoholic Fatty Liver Disease. [PDF]
Homayounfar N +3 more
europepmc +1 more source
Mechanisms of Non-alcoholic Fatty Liver Disease and Beneficial Effects of Semaglutide: A Review [PDF]
Sultan A. Alfawaz +2 more
openalex +1 more source
Prevalence and Risk Factors of Celiac Disease in Patients With Non-Alcoholic Fatty Liver Disease: A Meta-Analysis. [PDF]
Keetha NR +10 more
europepmc +1 more source

